載入...
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States ☆
INTRODUCTION: In the United States, routine human papillomavirus (HPV) vaccination is recommended for females and males at age 11 or 12 years; the series can be started at age 9 years. Vaccination is also recommended for females through age 26 years and males through age 21 years. The objective of t...
Na minha lista:
| 發表在: | Vaccine |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6745692/ https://ncbi.nlm.nih.gov/pubmed/29887325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.04.071 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|